Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Zepbound (same molecule, different brand) is FDA-approved for obesity, but Zepbound isn't on most Medicaid formularies yet
Through the years, GLP-1s have improved after exenatide (Byetta), we saw liraglutide (Victoza / Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic / Wegovy), and tirzepatide (Mounjaro / Zepbound)
If you've seen headlines suggesting otherwise, they're almost certainly referring to trial milestones, not regulatory approval
Citations UK Healthcare Staff
Protein intake becomes particularly important during this phase, and it is also where partners can play a genuinely practical role.(4) The appetite suppression produced by GLP-1 medications can make it difficult to reach protein targets when overall food intake drops significantly
Specific cohorts were developed for secondary outcomes to maximize the number of patients included in each study
